Innovate for Collective Impact to End Malaria

East Court/Lecture RoomsNational Academy of SciencesWashington, D.C. USA January 11, 2019

3

Foreword

For the second consecutive year, the World Health Organization (WHO) 2018 World Malaria Report confirms that global efforts to fight malaria have hit a plateau. Although there have been pockets of progress, the truth is that, at the global level, the great achievements of the past 20 years have stalled, and the world is still far from reaching the 2020 targets.

Recognizing that we need to do things in a different manner, the WHO and the RBM Partnership to End Malaria launched the “High burden to high impact: a targeted malaria response” strategy, a country-focused and -led plan to support countries with high disease burden. However, greater efforts from the global health community will be needed if we want to achieve the goal of eradicating malaria once and for all.

Research and development for malaria is paramount at this stage. We need to tightly integrate evidence-based decision-making, problem-solving, and innovation into the creation of effective new tools and strategies that replace—or complement—those currently in use. In addition, we also need to achieve the financial stability that guarantees continuity of the fight against malaria, including making a clear and definitive case for the economic benefits of malaria reduction and elimination to relevant stakeholders.

Now more than ever, partnerships across sectors will be a critical element toward progress against this age-old scourge. Therefore, today’s gathering of actors from diverse sectors of the global health community—including academia, civil society/nonprofit organizations, and local National Malaria Programs—is an excellent starting point to identify the barriers that have led us to the current situation, and to define the best way forward in the fight against malaria.

As General Director of the Barcelona Institute for Global Health (ISGlobal)—a WHO Collaborating Centre in Malaria Control, Elimination, and Eradication since 2013—I am delighted to welcome you to the “Innovate for Collective Impact to End Malaria” Symposium. Today’s event is sponsored by the Malaria Eradication Scientific Alliance (MESA Alliance) in partnership with the Harvard T.H. Chan School of Public Health and organized in collaboration with the American Society of Tropical Medicine and Hygiene; Barcelona Institute for Global Health (ISGlobal), Friends of the Global Fight to Fight Against AIDS, Tuberculosis, and Malaria; Harvard University’s Defeating Malaria: From the Genes to the Globe Initiative; and the U.S. National Institute of Allergy and Infectious Diseases.

Sincerely,

Antoni Plasència, MD, MPH, PhDDirector GeneralBarcelona Institute for Global Health

4

Background

After a significant decline in malaria cases and deaths over the past decade, estimates from the World Health Organization (WHO) flagship malaria publication—2018 World Malaria Report—point to a stall in the progress over the past two years. Whereas the estimated people with malaria steadily fell from 239 million in 2010 to 214 million in 2015, an estimated 219 million cases of malaria were reported in 2017. At the same time, 46 countries have fewer than 10,000 cases, and of these, 21 countries are targeting elimination of malaria transmission by 2020. The global plateau in malaria morbidity and mortality contrasts with the significant progress towards elimination in a number of countries.

This sobering new data is a stark reminder that innovation—from biomedical research and the adaptation of technical solutions/tools for local contexts to narrowing global finance gaps—will be a critical element to both sustaining the gains achieved over the past ten years and advancing the goal of eradication.

In addition to current efforts to shore up financial and political support for the Global Fund to Fight for AIDS, TB, and Malaria, the global malaria community will need to explore new opportunities for innovative financing (e.g., new country-level investments from governments in malaria endemic countries, expanded engagement with the private sector, philanthropy, and civil society in all countries, and cross sectoral collaborations) for long-term success to combat malaria.

At a critical time in the fight against malaria, a global gathering of key stakeholders will participate in the 2019 “Innovate for Collective Impact to End Malaria” meeting. Together, we will discuss and prioritize findings from the 2018 World Malaria Report and develop innovative approaches to collective bridge issues in malaria eradication spanning research, financing, and implementation. This dialog will consider the diversity of challenges across countries as well as the opportunities afforded by socioeconomic development, improved communication systems, and most importantly, the aspirations of the countries themselves.

This meeting is sponsored by the Malaria Eradication Scientific Alliance (MESA Alliance) and the Harvard T.H. Chan School of Public Health, and organized in collaboration with the American Society of Tropical Medicine and Hygiene; Barcelona Institute for Global Health (ISGlobal), Friends of the Global Fight to Fight Against AIDS, Tuberculosis, and Malaria; Harvard University’s Defeating Malaria: From the Genes to the Globe Initiative; and the U.S. National Institute of Allergy and Infectious Diseases.

5

About Malaria Eradication Scientific AllianceThe mission of the MESA Alliance is based on the core principles of driving scientific rigor, accelerating innovation, expanding inclusiveness, ensuring transparency, and cultivating agility. The MESA Alliance supports the global malaria community by providing a dedicated platform to drive an evidence-based approach to global malaria eradication; creating knowledge management tools to accelerate and expand the impact of the relevant evidence base; and accelerating research, especially in areas relevant for policy makers and programmes.

The MESA Alliance is supported by a grant from the Bill & Melinda Gates Foundation, and is hosted by the Barcelona Institute for Global Health (ISGlobal), which is a World Health Organization (WHO) Collaborating Centre for Malaria Control, Elimination, and Eradication.

About Harvard T.H. Chan School of Public Health and Harvard University’s Defeating Malaria: From the Genes to the Globe InitiativeHarvard T.H. Chan School of Public Health traces its roots to public health activism at the beginning of the last century, a time of energetic social reform. From the start, faculty were expected to commit themselves to research as well as teaching. The Harvard Chan brings together dedicated experts from many disciplines to educate new generations of global health leaders and produce powerful ideas that improve the lives and health of people everywhere. The Harvard Chan—and the wider university—has had a long history of pursuing and advancing malaria research, education, and leadership development. More recently, the university formally established the Defeating Malaria: From the Genes to the Globe Initiative—a cross-school effort to produce, transmit, and translate knowledge to support the control and ultimate eradication of malaria.

Through this faculty-led initiative, Harvard contributes to bridging intellectual and operational gaps in malaria research, knowledge, and training to create sustained, real world impact. Harvard’s Defeating Malaria Initiative is centered on fostering multidisciplinary collaboration on global challenges, establishing new types of external partnerships, and serving as an inspiration and rallying cry for others to join the fight.

6

Meeting agenda 8:00AM(East Court Room)

Registration & Coffee

8:30AM(Lecture Room)

Welcome & Opening RemarksSpeaker: Regina Rabinovich, MD, MPH, Director, Malaria Eradication Scientific Alliance, Barcelona Institute for Global Health (ISGlobal); ExxonMobil Malaria Scholar in Residence at Harvard University

9:00AM

Opening Session: Mapping the Trajectory—Implications of the 2018 World Malaria ReportIntroduction: Chandy C. John, MS, MD, FASTMH, Ryan White Endowed Chair in Pediatric Infectious Diseases, Indiana UniversitySpeaker (via video conference): Pedro L. Alonso, MD, PhD, Director, Global Malaria Program, World Health Organization (WHO)

9:40AM

Panel Session: Overcoming Finance Obstacles for SustainabilitySession Chair: Alan Court, MSc, Special Advisor, WHO Ambassador for Global StrategyPanelists:Olusoji Adeyi, MD, MBA, DrPH, Director, Health, Nutrition, and Population Global Practice, World Bank GroupMark Dybul, MD, Professor of Medicine and Faculty Co-Director, Center for Global Health and Quality, Georgetown University Medical Center

10:15AM(East Court Room)

Break

10:30AM

Panel Session: Resistance as a Driver for Innovation Session Chair: Lee Hall, MD, PhD, Chief, Parasitology and International Programs Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious DiseasesPanelists:Abdoulaye Djimdé, PhD, Associate Professor of Microbiology and Immunology, Chief of the Molecular Epidemiology and Drug Resistance Unit, University of Bamako David A. Fidock, PhD, Professor of Microbiology & Immunology and of Medical Sciences, Columbia University Medical Center Christen Fornadel, PhD, Technical Coordinator, IVCCCarol Sibley, PhD, Professor of Genome Sciences, University of Washington and Founder and Senior Scientific Advisor, WorldWide Antimalarial Resistance Network

11:15AM

Keynote AddressIntroduction: Rose Leke, PhD, Emeritus Professor of Immunology and Parasitology, University of Yaoundé I Speaker: Anthony S. Fauci, MD, Director, National Institute of Allergy and Infectious Diseases

11:45AM

Panel Session: Capitalizing on Novel Technologies to Combat MalariaSession Chair: Dyann F. Wirth, PhD, Richard Pearson Strong Professor of Infectious Diseases, Harvard T.H. Chan School of Public HealthPanelists:John H. Adams, PhD, Distinguished University Professor, College of Public Health/Global Health, University of South FloridaRebeca Carballar, Senior Scientist of Microbiology & Molecular Genetics, University of California, Irvine (via video conference)Anthony A. James, Professor of Microbiology & Molecular Genetics and Professor of Molecular Biology & Biochemistry, University of California, Irvine (via video conference)Elizabeth A. Winzeler, PhD, Professor of Pediatrics, University of California, San Diego

7

12:15PM(East Court Room)

Lunch

1:00PM

Panel Session: Maximizing Innovations in High-burden Country SettingsSession Chair: Regina Rabinovich, MD, MPHPanelists:Laurence Slutsker, MPH, MD, Program Leader, Malaria and Neglected Tropical Diseases; Director, Center for Malaria Control and Elimination at PATHAlex Rowe, MPH, MD, Chief, Strategic and Applied Science Unit, Malaria Branch, Center for Global Health, U.S. Centers for Disease Control and PreventionRick Steketee, MD, Deputy Global Malaria Coordinator, U.S. President’s Malaria Initiative Stefan Swartling Peterson, MD, PhD, Professor of Global Health, Uppsala University and Chief, Health Section, UNICEFPradipsinh K. Rathod, PhD, Professor of Chemistry and Adjunct Professor of Global Health, University of Washington

1:30PM

Panel Session: The Search for New ToolsSession Chair: Kent E. Kester, MD, Vice President and Head, Translational Science and Biomarkers, Sanofi PasteurPanelists:Jean-Luc Bodmer, MBA, PhD, Senior Program Officer for Malaria, Global Health Program, Bill & Melinda Gates FoundationRobert Seder, MD, Chief, Cellular Immunology Section, National Institute of Allergy and Infectious Diseases Robert Sauerwein, MD, PhD, Professor of Medical Microbiology, Radboud University Medical CenterDyann F. Wirth, PhD

2:00PM

Panel Session: Messaging Complexities in the Malaria StorySession Chair: Joshua Blumenfeld, JD, MA, Managing Director, Malaria No MorePanelists:Chris Collins, MPP, President, Friends of the Global Fight Against AIDS, Tuberculosis, and Malaria Ben Humphrey, MSJ, Senior Director, Global Health StrategiesMargaret McDonnell, MPP, Executive Director, United Nations Foundation’s Nothing but Nets Campaign

2:30PM

Panel Session: Planning for ProgressSession Chair: Gonzalo Fanjul, MPA, Policy Director, ISGlobalPanelists:Jean Luc Bodmer, MBA, PhD; Lee Hall, MD, PhD; Stefan Swartling Peterson, MD, PhD; Rick Steketee, MD; and Regina Rabinovich, MD, MPH

3:00PMClosing RemarksSession Chairs: Rafael Villasanjuan, Director of Policy and Global Development, ISGlobal and Regina Rabinovich, MD, MPH

3:15PM Adjourn

8

John H. Adams, PhDDistinguished University ProfessorCollege of Public Health/Global Health, University of South Florida

Professor John H. Adams, joined the University of South Florida College of Public Health/Global Health Infectious Diseases Research Program in June 2007. Previously, he was at the University of Notre Dame for 16 years. His research program studies malaria parasite biology with the expectation that a better understanding of Plasmodium biology will enable developing better ways to control malaria through vaccines, drugs and other prevention strategies.

Professor Adams was trained in basic parasitology earning a bachelor’s degree at the Hendrix College and a Doctor of Philosophy at the University of Illinois and served as a Postdoctoral Fellow at the University of Queensland. After completing his training, he worked in molecular approaches to malaria at the U.S. National Institutes of Health.

Olusoji Adeyi, MD, MBA, DrPHDirector, Health, Nutrition, and Population Global PracticeWorld Bank Group

Dr Olusoji Adeyi, is Director of the Health, Nutrition and Population Global Practice at the World Bank Group. He serves as the World Bank’s Sector Manager for Health, Nutrition, and Population in Eastern and Southern Africa, with responsibilities for the institution’s support for policies, strategies, and programs in the region. Dr Adeyi was Founding Director of the Affordable Medicines Facility-malaria at the Global Fund to Fight AIDS, Tuberculosis, and Malaria.

Formerly coordinator of public health programs at the World Bank, Dr Adeyi led a number of initiatives on global public health policies and strategies, and analyses of the integration of health systems and health interventions. He has extensive experience in policies, strategies and programs for health systems, service delivery and disease control at the global, regional and country levels in Africa, Eastern Europe, and Central Asia. He has also had responsibilities with the Federal Ministry of Health in Nigeria, the World Health Organization, the Joint United Nations Programme on HIV/AIDS, and the Harvard T.H. Chan School of Public Health. He has authored research papers and books on service delivery, quality of care, maternal health, health financing, HIV/AIDS, tuberculosis, malaria, and chronic non-communicable diseases.

Speaker Biographies

9

Pedro L. Alonso, MD, PhDDirector, Global Malaria Programme

World Health Organization

Dr Pedro L. Alonso is the director of the Global Malaria Programme at the World Health Organization (WHO) in Geneva, Switzerland. The Global Malaria Programme is responsible for the coordination of WHO’s global efforts to control and eliminate malaria and sets evidence-based norms, standards, policies, and guidelines to support malaria-affected countries around the world.

Dr Alonso has spent over 30 years in public health, having started his career as a physician working in West Africa. His past scientific research focused on the key determinants of morbidity and mortality in the most vulnerable population groups. He has published over 300 articles in international peer-reviewed journals, primarily on malaria treatment, vaccine trials, and preventive therapies, and he has served on several national and international committees. Dr Alonso is committed to capacity building of both institutions and individuals, primarily in Africa. Prior to taking on his current position at WHO, Dr Alonso served as director of the Barcelona Institute for Global Health, professor of Global Health at the University of Barcelona, and president of the governing board of the Manhiça Foundation and the Manhiça Health Research Center in Mozambique.

Joshua Blumenfeld, JD, MAManaging Director

Malaria No More

Mr Joshua Blumenfeld is the Managing Director of Malaria No More, where he leads a global advocacy team in engaging with governments, multilateral institutions, as well as U.S. and internationally based public and private partners to advance malaria elimination. Previously, Mr Blumenfeld served in the Obama Administration as Deputy Assistant Secretary of State for Senate Affairs, where he advised Secretaries Clinton and Kerry, as well as other senior department leadership on advancing the administration’s foreign policy, national security, and development priorities in Congress. While at the State Department, he also served as the Acting Director of the Quadrennial Diplomacy and Development Review, where he helped launch the 2014 strategic policy and management review of the Department. Prior to joining the Obama administration, Mr Blumenfeld worked in the U.S. Senate as Senior Foreign Policy Advisor to Senator Chris Dodd. He also served as Staff Director for the Senate Foreign Relations Subcommittee on the Western Hemisphere, and as Director of the Senate India Caucus. He earned a Juris Doctor from the Georgetown University Law Center, an master’s of arts from the London School of Economics. He is also an Adjunct Professor at the University of Pennsylvania.

10

Jean-Luc Bodmer, MBA, PhDSenior Program Officer, Malaria, Global Health ProgramBill & Melinda Gates Foundation

Dr Jean-Luc Bodmer is Senior Program Officer on the Malaria Program Strategy Team. Trained as a biochemist with expertise in vaccine product development, he joined the Bill & Melinda Gates Foundation (BMGF) in September 2017 to oversee investments related to malaria vaccines and monoclonal antibodies.

Before joining the BMGF, Jean-Luc worked in various roles in product development in the biotechnology and pharmaceutical industry. Most recently, he was head of CMC analytics and brand manager for inflammatory bowel disease product commercialization at Seres Therapeutics, a microbiome therapy company in Cambridge, MA. Prior to working at Seres, Jean-Luc led the BMGF-funded T cell antigen discovery effort on malaria at Genocea Biosciences (as a grantee of the BMGF in 2014). He also helped to launch a start-up company at the Swiss Federal Institute of Technology (ETH Lausanne) aimed at developing an affordable and portable device to measure the microbiological quality of drinking water. Prior to that, Jean-Luc spent 8 years in Chemistry Manufacturing and Controls and Lead Discovery at Merck & Co, Inc. Vaccine Division, developing innovative analytical tools for commercial and investigational vaccines and has led the internal vaccine program for Clostridium difficile infections from target identification to clinical lead selection.

He earned a bachelor’s degree and master’s degree in Biochemistry from the University of Geneva in Switzerland, and a Doctor of Philosophy in Cell Biology from the University of Lausanne. He recently graduated from MIT’s Sloan School of Management with a master’s degree in Business Administration.

Rebeca Carballar, PhDSenior Scientist of Microbiology & Molecular Genetics School of Medicine, University of California, Irvine

Dr Rebeca Carballar is a Senior Scientist of Microbiology & Molecular Genetics in the School of Medicine at the University of California, Irvine. She has experience in insect molecular genetics, vector biology, and the development of insect genetic technologies. She is currently working on the development and optimization of a gene drive systems based on CRISPR-Cas9 technology for population modification of the African malaria vector Anopheles gambiae.

Speaker Biographies

11

Chris Collins, MPPPresident

Friends of the Global Fight Against AIDS, Tuberculosis, and Malaria

Mr Chris Collins leads the Friends for the Global Fight Against AIDS, Tuberculosis, and Malaria efforts to educate and engage U.S. decision makers on the lifesaving work of the Global Fund to Fight AIDS, Tuberculosis and Malaria and the effort to end these three epidemics. Previously, as Chief of the Community Mobilization Division at UNAIDS, Chris helped make the case for investment in civil society as an essential part of the AIDS response.

As Vice President and Director of Public Policy at amfAR, the Foundation for AIDS Research, Chris defended global AIDS research and program funding and worked to advance domestic HIV policy and global key populations programming. Chris also helped drive the creation of the first comprehensive U.S. National HIV/AIDS Strategy; helped develop and managed the International Treatment Preparedness Coalition (ITPC) Missing the Target series of reports on global HIV treatment scale up; and co-founded and served as Executive Director at AVAC, a global HIV research and prevention advocacy group. As appropriations staff to U.S. Representative Nancy Pelosi (D-CA) in the 1990s, Chris designed the first legislation to provide incentives for development and delivery of vaccines against HIV, TB, and malaria. He earned a master’s degree in Public Policy from Harvard University.

12

Speaker Biographies

Alan Court, MScSenior AdviserWorld Health Organization’s Ambassador for Global Strategy

Mr Alan Court is Senior Adviser to the World Health Organization’s Ambassador for Global Strategy, Mr Ray Chambers. Prior to this position, Mr Court served as an advisor to the UN Secretary-General’s Special Envoy for Financing the Health Millennium Development Goals and For Malaria and also had a long and distinguished career with UNICEF. Until 2008 he was the Director of the UNICEF Programme Division, where he oversaw programme policy, guidance and management that assisted staff in the implementation of programmes and played a central role in guiding them towards the achievement of the Millennium Development Goals.

Between 2000 and 2005 Mr. Court served as Director of the UNICEF Supply Division in Copenhagen, where he was credited with turning the division’s function into an innovative and cutting edge one that provided essential commodities and services to Governments through a mix of program and procurement services that directly impacted implementation as well as delivery performance specially in Humanitarian Emergencies. Mr Court has had a long and distinguished career in the field including postings as UNICEF Country Representative in India; Deputy Regional Director of the Americas and Caribbean region in Bogotá, Colombia; Representative in Bolivia; Special Representative in the former Yugoslavia; and Representative in Chad. He also served in Nepal, Ethiopia, Indonesia, and Bangladesh. Prior to his UNICEF career, Mr Court worked with non-government organizations in Bangladesh and in education in the United Kingdom. Mr Court holds a master’s degree in Rural Social Development from the University of Reading School Of Education in the United Kingdom.

13

Abdoulaye Djimdé, PhDAssociate Professor of Microbiology and Immunology

Chief of the Molecular Epidemiology and Drug Resistance UnitMalaria Research and Training Centre, University of Bamako

Abdoulaye Djimdé is Associate Professor of Microbiology and Immunology and Chief of the Molecular Epidemiology and Drug Resistance Unit at the Malaria Research and Training Centre University of Bamako, Mali. There he leads a dynamic research group whose primary focus is to understand how variations in the genomes of the malaria parasite, the human host, and the mosquito vector relate to disease outcomes like the spread of antimalarial drug resistance. His translational research programme uses molecular and genetic approaches to tackle important problems in malaria control. Professor Djimdé earned a Doctor of Pharmacy in 1988 from the University of Bamako, Mali, and then started a private pharmacy. He was a research assistant at the Malaria Research and Training Centre in Bamako, and after began a doctoral training programme under the supervision of Professor Christopher V. Plowe at the University of Maryland and Dr Thomas E. Wellems at the National Institutes of Health. During this time, Professor Djimdé authored a number of notable papers, describing the first reliable molecular marker for chloroquine-resistant malaria and a model for using molecular markers to monitor drug resistant malaria in the field. As a strong proponent of capacity building for African research and collaborative research networks, he is also involved in good citizenship within the African research community. He was instrumental in the formation of the Worldwide Antimalarial Drug Resistance Network, on whose Scientific Advisory Board he serves. He has also served as Chair of the Multilateral Initiative on Malaria Task Force within the World Health Organization (WHO) Tropical Disease Research Programme (TDR), where he helped to manage the process for awarding research grants in Africa. Currently he serves as coordinator of the West African Network for Clinical Trials of Antimalarial Drugs, with funding from the European and Developing Countries Clinical Trials Partnership to conduct multicentre phase III studies in Mali, Burkina Faso and Guinea.

14

Mark Dybul, MDFaculty Co-Director of the Center for Global Health and QualityProfessor in the Department of MedicineGeorgetown University Medical Center

Professor Mark Dybul is the Faculty Co-Director of the Center for Global Health and Quality and Professor in the Department of Medicine at Georgetown University Medical Center. A well-recognized global health expert and humanitarian leader, Professor Dybul served as executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). Professor Dybul was a HIV research fellow at the National Institute for Allergy and Infectious Diseases under director Dr Anthony Fauci in the late 1990s. There, he conducted basic and clinical HIV research, and eventually conducted the first randomized controlled trial with combination antiretroviral therapy with HIV patients in Africa. He went on to lead President George W. Bush’s International Prevention of Mother and Child HIV initiative for the Department of Health and Human Services, and in 2006 was named U.S. Global AIDS Coordinator. In this role, he led the implementation of the President’s Emergency Plan for AIDS Relief, a health initiative that Professor Dybul helped create. He later became the inaugural Global Health Fellow of the George W. Bush Institute.

Gonzalo Fanjul, MPAPolicy DirectorBarcelona Institute of Global Health

Mr Gonzalo Fanjul is a policy researcher and activist with two decades of experience in Spain, Peru and the United States. Originally trained as an economist, he later completed studies on poverty and international development issues and earned a master’s degree in Public Policy from Harvard Kennedy School.

Between 1998 and 2011 he was Research Director and Senior Strategic Advisor in Intermón Oxfam and Oxfam International. Since then, he has joined the Barcelona Institute of Global Health (ISGlobal) Think Tank as an associate researcher, working in the development of organization’s international strategy. In September 2014, he was appointed Director of ISGlobal’s Policy area. He is also the founder of porCausa, an initiative of journalism and research against poverty. He is the author and co-editor of El País’ blog 3.500 Millones and collaborates often in other media. He has published numerous policy papers in the fields of global health, international migrations, food security, trade, and development aid.

Speaker Biographies

15

Anthony S. Fauci, MD Director

National Institute of Allergy and Infectious Diseases

Dr Anthony S. Fauci, is a physician-scientist and director of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) in Bethesda, Maryland. He oversees an extensive research program on infectious diseases such as HIV/AIDS, influenza, tuberculosis, Ebola, and Zika, as well as diseases of the immune system. Dr Fauci also serves as one of the key advisors to the U.S. Department of Health and Human Services and White House on global infectious disease issues.

He was one of the principal architects of the U.S. President’s Emergency Plan for AIDS Relief, a program that has saved millions of lives throughout the developing world. Dr Fauci also is the long-time chief of the NIAID Laboratory of Immunoregulation where he has made numerous important discoveries related to HIV/AIDS and is one of the most-cited scientists in the field. He is a member of the U.S. National Academy of Sciences and the U.S. National Academy of Medicine and has received numerous prestigious awards for his scientific and global health accomplishments, including the National Medal of Science, the Robert Koch Medal, the Mary Woodard Lasker Award for Public Service, and the U.S. Presidential Medal of Freedom. He has been awarded 45 honorary doctoral degrees and is the author, coauthor, or editor of more than 1,300 scientific publications, including several major textbooks.

16

Speaker Biographies

David A. Fidock, PhDProfessor of Microbiology & Immunology and of Medical Sciences Program Director, Graduate Program in Microbiology, Immunology, & InfectionColumbia University Medical Center

Professor David A. Fidock is Professor of Microbiology & Immunology and of Medical Sciences at the Columbia University Medical Center and Program Director of the Columbia University Graduate Program in Microbiology, Immunology, and Infection. He received a bachelor’s degree in Mathematical Sciences with Honors from Adelaide University in Australia and a Doctor of Philosophy in Microbiology from the Pasteur Institute in Paris, France. Following postdoctoral research training at the University of California, Irvine with Professor Anthony James and at the National Institutes of Health with Dr Thomas Wellems, he started his independent group at the Albert Einstein College of Medicine in New York in 2000. He moved to Columbia University in 2007.

His research program focuses on the genetic and molecular basis of antimalarial drug resistance in Plasmodium falciparum, drug discovery, genetically attenuated vaccines, and parasite lipid metabolism. He has authored 190 articles on malaria. In 2014, the American Society of Tropical Medicine and Hygiene (ASMTH) awarded Dr Fidock the Bailey K. Ashford Medal for distinguished work in tropical medicine, and in 2015, he was elected to the ASTMH Council. In 2016, he was named Global Australian of the Year in Life Sciences; in 2017, he was awarded the endowed C.S. Hamish Young Professorship. He is on the Antimalarial Drug Resistance Advisory Group for the World Health Organization.

Christen Fornadel, PhDTechnical CoordinatorIVCC

Dr Christen Fornadel is formally trained as an entomologist and serves as the Technical Coordinator for IVCC’s UNITAID/Global Fund-funded New Nets Project. At IVCC, Christen provides coordination, oversight, and guidance in support of country activities related to the launch, monitoring, and evaluation of novel vector control products.

Prior to joining IVCC, Dr Fornadel was a senior malaria vector control specialist with the U.S. President’s Malaria Initiative (PMI). At PMI, she contributed to global strategy and country-level planning for malaria mosquito control, including entomological monitoring, insecticide-resistance management, and implementation of indoor residual spraying and long-lasting insecticide treated nets. Before joining PMI, she completed her graduate studies at the Johns Hopkins Bloomberg School of Public Health, where her doctoral research focused on the foraging behavior of malaria mosquitoes in rural Zambia. Prior to her graduate work at Hopkins, she completed a Fulbright fellowship in Australia, performing laboratory and field studies on a vaccine against the hydatid disease tapeworm.

17

B. Fenton (Lee) Hall, MD, PhD Chief, Parasitology and International Programs Branch

Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases

Dr B. Fenton (Lee) Hall has been the chief of Parasitology and International Programs Branch (PIPB) at the National Institute of Allergy and Infectious Diseases (NIAID) since 2005. In this role, he oversees multiple programs involving grants and contracts that support basic, translational, and clinical research, and development in parasitology and vectors responsible for transmission of parasites.

In 1991, Dr Hall served as a medical officer and Host Immunity program officer in the PIPB. In the ensuing years, he developed a new program focused on vaccine research and development for parasitic diseases, and in 2000, he became chief of the Malaria Vaccine Development Section. In that capacity, he provided oversight and direction for a program of research grants, contracts, and collaborative agreements including basic immunologic research, target identification and validation, translational research and development activities, and clinical evaluation of promising vaccine candidates domestically and internationally. He has also served on numerous committees for federal and international activities involving vaccine research and development and global health, and has chaired and participated in numerous scientific symposia on vaccine research and development and tropical infectious diseases at national and international meetings. Dr Hall earned a bachelor’s degree from Harvard College and a Medical degree and a Doctor of Philosophy in Immunology from the New York University School of Medicine. He completed his residency training in Internal Medicine at the Johns Hopkins Hospital, and Infectious Diseases subspecialty training at the National Institutes of Health and Yale University School of Medicine.

Ben Humphrey, MSJSenior Director

Global Health Strategies

As Senior Director at Global Health Strategies, Mr Humphrey drives communications and advocacy initiatives for a range of international organizations. Since joining the company in 2011, he has helped build support for a variety of health and development priorities, including malaria control and elimination; replenishment efforts to support the Global Fund to Fight AIDS, Tuberculosis, and Malaria; polio eradication; cervical cancer prevention and control. Previously, Mr Humphrey was a reporter for Agence-France Presse in Johannesburg, South Africa and spent four years with Allegis Group Inc. tackling workforce management challenges in the health care, financial services, and defense industries. Mr Humphrey earned a master’s degree from Northwestern University’s Medill School of Journalism, and a bachelor’s degree in Communications from Wake Forest University.

18

Chandy C. John, MD, MSRyan White Professor of PediatricsIndiana University

Professor Chandy C. John, holds the Ryan White endowed chair in Pediatric Infectious Diseases and is director of the Ryan White Center for Pediatric Infectious Disease and Global Health at Indiana University. Professor John is an active clinician, specializing in pediatric infectious diseases and tropical medicine. His research focuses on malaria pathogenesis, immunology, and epidemiology. He maintains ongoing research and training programs in Kenya in collaboration with colleagues at the Kenya Medical Research Institute and Moi University and in Uganda in collaboration with colleagues at Makerere University. Professor John is the author of more than 150 peer-reviewed publications and 30 book chapters. He is the recipient of the 2004 Pediatric Infectious Diseases Society’s Young Investigator Award, the 2011 American Society of Tropical Medicine and Hygiene (ASTMH) Bailey K. Ashford Medal, and currently serves as the president-elect of ASTMH.

Anthony A. JamesProfessor of Microbiology & Molecular Genetics, School of Medicine,Professor of Molecular Biology & Biochemistry, School of Biological SciencesUniversity of California, Irvine

Professor Anthony A. James is Donald Bren Professor of Microbiology & Molecular Genetics in the School of Medicine and Molecular Biology & Biochemistry in the School of Biological Sciences at the University of California, Irvine. His research group uses genetics as the basis for synthetic approaches to prevent transmission of mosquito-borne diseases. Contributions include the development of mosquito transgenesis procedures, engineered genes that interfere with malaria parasite or dengue virus development in mosquitoes, a population-suppression strain based on flightless female mosquitoes and gene-drive systems to spread beneficial genes quickly through mosquito populations. Professor James is a member of the U.S. National Academy of Sciences.

Speaker Biographies

19

Kent E. Kester, MDVice President and Head, Translational Science, and Biomarkers

Sanofi Pasteur

Dr Kent E. Kester is currently Vice President and Head, Translational Science and Biomarkers at Sanofi Pasteur. In this capacity, he leads a team of over 200 research and clinical professionals in the U.S. and France focused on the translational development of new vaccines.

During a 24-year career in the U.S. Army, he worked extensively in clinical vaccine development and led multiple research platforms at the Walter Reed Army Institute of Research, the U.S. Department of Defense’s largest and most diverse biomedical research laboratory, an institution he later led as its Commander/Director. His final military assignment was as the Associate Dean for Clinical Research in the School of Medicine at the Uniformed Services University of the Health Sciences (USUHS). During his military service, Dr Kester was appointed as the lead policy advisor to the U.S. Army Surgeon General in both Infectious Diseases and in Medical Research & Development. In these capacities, he worked extensively in the interagency environment and developed a variety of Army medical policies related to infectious diseases, both clinical and research aspects.

Dr Kester is a Medical Doctor from Jefferson Medical College, completing his internship and residency in internal medicine at the University of Maryland and a research fellowship in infectious diseases at the Walter Reed Army Medical Center. Currently a member of the U.S. Government Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, he previously chaired the Steering Committee of the NIAID/USUHS Infectious Disease Clinical Research Program, and has served as a member of the FDA Vaccines & Related Biologics Products Advisory Committee (VRBPAC), the NIAID Advisory Council, and the CDC Office of Infectious Diseases Board of Scientific Counselors. Board-certified in both internal medicine and infectious diseases, Dr Kester holds active faculty appointments at USUHS and the University of Maryland; and is a fellow of the American College of Physicians, the Royal College of Physicians of Edinburgh, the Infectious Disease Society of America, and the American Society of Tropical Medicine and Hygiene. He is a member of the clinical faculty at the University of Maryland Shock Trauma Center in Baltimore as well as the Wilkes-Barre VA Medical Center, Wilkes-Barre, PA.

20

Speaker Biographies

Rose Leke, PhDEmeritus Professor of Immunology and ParasitologyFaculty of Medicine and Biomedical Sciences, University of Yaoundé I

Professor Rose Leke is Emeritus Professor of Immunology and Parasitology at the University of Yaoundé I in Cameroon. Her primary research interests center on the immunology of parasitic infections, in particular, malaria. Professor Leke has a keen interest in global health issues and has been involved in the worldwide Polio Eradication Initiative, global malaria elimination activities, and health systems strengthening efforts. She has been very effective in the training of the next generation of scientists, namely the empowerment of the young female scientists and women overall. Higher Women Cameroon, a high-impact mentoring program, is one of her primary initiatives.

Since stepping down from her academic position at the University of Yaoundé I in 2013, Professor Leke has served in many distinguished roles. She is executive director of the Cameroon Coalition against malaria; chair of the Multilateral Initiative on Malaria (MIM) Secretariat; president of the Federation of African Immunological Societies, fellow of the Cameroon Academy of Sciences CAS, fellow of the African Academy of Science AAS, fellow of the World Academy of Science, and two- term council member of the International Union of Immunological Societies. She has served as a consultant on several past/current committees of the WHO, including Malaria Policy Advisory Committee, Malaria Elimination Oversight Committee, Global Certification Commission, Emergency Committee for Polio Eradication, and the Chair of the African Regional Commission for the Certification of the Eradication of Poliomyelitis. She also served as Chair of the Data Management Committee for a trial on Azithromycin-chloroquine. She is the recipient of numerous awards and honors, including elected as a Heroine of Health in a globally recognized ceremony (with nine other female honorees) and crowned by the Cameroon Medical Council as Queen Mother of the Cameroonian Medical Community in 2018.

21

Margaret McDonnell, MPPExecutive Director, Nothing but Nets

United Nations Foundation

Ms Margaret McDonnell is the Executive Director of the United Nations Foundation’s Nothing But Nets campaign, the world’s largest and most powerful community of supporters and advocates committed to saving lives and defeating malaria. In addition to raising funds for its UN partners, Nothing But Nets raises awareness and voices to advocate for critical malaria funding for the U.S. President’s Malaria Initiative and The Global Fund to Fight AIDS, Tuberculosis, and Malaria.

Before joining Nothing But Nets, Margaret ran strategic partnerships and worked on the grassroots engagement and advocacy portfolio with the ONE Campaign covering a wide range of global health and poverty issues. She worked with UNICEF in Botswana to develop media and civil society engagement strategies to further children’s rights and as a consultant for the U.S. Coalition for Child Survival to identify and implement advocacy and coalition-building best practices. She earned a Master in Public Policy with a focus on global health from George Mason University and a broad range of experience in issue-based and political campaigning, non-profit fundraising, and international development.

Stefan S. Peterson, MD, PhDChief of Health Section, UNICEF

Professor of Global Health, Uppsala University

Professor Stefan Swartling Peterson was appointed Associate Director, Programme Division, and Chief of Health in April 2016. Prior to his appointment at UNICEF, he was a Professor of Global Health at Uppsala University, Sweden, and, prior to that, at the Global Health Division of Karolinska Institutet, Sweden. He has also been a visiting professor at Makerere University in Uganda.

As a health systems researcher and physician, Professor Peterson did extensive field work in Tanzania and Uganda, and worked with different ministries of health, and organizations such as the World Health Organization (WHO). He implemented projects supported by Swedish International Development Cooperation Agency (SIDA), the Gates Foundation, and the European Union. He was a co-founder of Médecins Sans Frontières Sweden and the CCM Task Force Operations Research Group. Professor Peterson is a medical doctor with advanced degrees in Medicine, Public Health and a Doctor of Philosophy in International Pediatrics.

22

Regina Rabinovich, MPH, MDExxonMobil Malaria Scholar in ResidenceHarvard T. H. Chan School of Public HealthDirector, Malaria Elimination InitiativeBarcelona Institute for Global Health

Dr Regina Rabinovich is a global health leader with over 25 years’ experience in the research, public health, and philanthropic sectors, with a focus on strategy, analytics, global health product development, and the introduction and scale-up of tools and strategies resulting in impact on endemic populations. Since 2012, she has served as the ExxonMobil Malaria Scholar in Residence at Harvard University and Chair of the Malaria Eradication Scientific Alliance (MESA), hosted at the Barcelona Institute for Global Health. As MESA Chair, she recently led the consultative process to ‘refresh’ the Malaria Eradication Research Agenda Refresh (malERA Refresh). Dr Rabinovich is past president of the American Society of Tropical Medicine and Hygiene. She serves on the boards of the National Institutes of Health’s Council of Councils, PATH Vaccine Solutions, Aeras, Sabin Vaccine Institute at Harvard, Catholic Medical Mission, and Harvard University’s Defeating Malaria: From the Genes to the Globe Initiative.

Prior to her role at Harvard University, Dr Rabinovich was the director of the Infectious Diseases Unit at the Bill and Melinda Gates Foundation where she oversaw the development and implementation of strategies for the prevention, treatment, and control of diseases of particular relevance to global health, including malaria, pneumonia, diarrhea, and neglected infectious diseases. During her tenure at the National Institute of Allergy and Infectious Diseases, she helped develop and evaluate vaccines. In addition to participating in the Children’s Vaccine Initiative and liaising on issues related to vaccine safety and vaccine research, she managed the evaluation of candidate vaccines through a network of United States clinical research units. During her time as director of the PATH Malaria Vaccine Initiative, she advanced efforts to develop promising malaria vaccine candidates.

Pradipsinh K. Rathod, PhDProfessor of Chemistry and an Adjunct Professor of Global Health University of Washington

Starting in 1982, Professor Pradip Rathod and collaborators have helped define good drug targets. They have also revealed how Plasmodium populations that are under drug pressure can arrive at mutations exactly where needed, without collateral damage elsewhere in their haploid genome. Rathod is also the Director of the U.S. National Institutes of Health (NIH)-sponsored International Centers of Excellence for Malaria Research (ICEMR) in South Asia. His team is currently hunting for specific global hot-spots that present the biggest challenges in our efforts to control malaria parasites. Such inquiries are essential for further improving strategies to control malaria globally.

Speaker Biographies

23

Alex Rowe, MPH, MDChief, Strategic and Applied Science Unit

Malaria Branch, Division of Parasitic Diseases and Malaria Center for Global Health, U.S. Centers for Disease Control and Prevention

Alex Rowe is Chief of the Strategic and Applied Science Unit, Malaria Branch, Division of Parasitic Diseases and Malaria at the Center for Global Health, U.S. Centers for Disease Control and Prevention in Atlanta, GA, USA. His research interests include: measuring the quality of care delivered by health workers in low- and middle-income countries (LMICs; understanding the factors that influence the quality of care; and developing and testing interventions to improve and maintain high-quality performance that are feasible and affordable in LMICs. Dr Rowe is currently working with the World Health Organization, Harvard Medical School, the World Bank, Johns Hopkins University, and Management Sciences for Health to conduct a systematic review of strategies to improve health worker performance in LMICs.

Robert Sauerwein, MD, PhDProfessor of Medical Parasitology

University of AmsterdamRadboud University Medical Center

Professor Robert Sauerwein is a physician and medical microbiologist by training at the University of Amsterdam and Radboud University Medical Center in the Netherlands. He has been conducting translational research in malaria over the past 30 years with focus on malaria transmission and clinical development of malaria vaccines. Since 1994, he has been leading the malaria research group and the largest facility for malaria parasite and mosquito breeding in Europe. His research programs cover malaria research from the molecular level to human populations. Two decades ago, Professor Sauerwein introduced the controlled human malaria infection model in the Netherlands to delineate immune mechanisms of protection, to find correlates of protection, and to test candidate drugs and vaccines. He is the co-founder of TropIQ Health Science, a company aiming to develop new drug interventions for vector-borne diseases. He has co-authored approximately 400 peer-reviewed publications and several book chapters. He earned a Doctor of Philosophy in B cell immunology in Amsterdam.

24

Speaker Biographies

Carol Sibley, PhDProfessor of Genome Sciences, University of WashingtonVisiting Professor, Nuffield Department of Medicine, University of OxfordFounder and Senior Scientific Advisor, WorldWide Antimalarial Resistance Network

Professor Carol Sibley is a Professor of Genome Sciences, University of Washington and a Visiting Professor in the Nuffield Department of Medicine at the University of Oxford. She is the founder and senior scientific advisor of the WorldWide Antimalarial Resistance Network (WWARN). As part of her malaria research activities, she has collaborated closely in field studies with colleagues in Kenya and Tanzania.

She has served on numerous advisory boards, the Medicines for Malaria Venture (MMV), ACT Consortium, the Malaria Capacity Development Consortium, Wellcome Trust DELTAs program, the MIM organizing committee and several of the NIH funded International Centers of Excellence in Malaria Research. She earned a bachelor’s degree and master’s degree in Biology from the University of Rochester, and earned a Doctor of Philosophy in Biochemistry and Biophysics from the University of California, San Francisco. She completed post-doctoral training at Caltech.

Robert Seder, MD Chief, Cellular Immunology SectionNational Institute of Allergy and Infectious Diseases

Dr Robert Seder is the Chief of the Clinical Immunology Section in the Laboratory of Clinical Investigation, part of the National Institute of Allergy and Infectious Diseases (NIAID) Division of Intramural Research since 1994. In 2000, he was appointed to a tenured position in the Vaccine Research Center (VRC), Laboratory of Immunology. Since joining the VRC, Dr Seder has focused his efforts on understanding the innate and adaptive mechanisms by which various vaccines approaches mediate protective antibody and T cell immunity in mouse, non-human primate, and human models of HIV, tuberculosis, and malaria infection. He is internationally recognized in the field of vaccine biology and cellular immunology and he currently serves as chief of the Cellular Immunology Section in the VRC.

Dr Seder earned a bachelor’s degree in Natural Science at Johns Hopkins University in 1981 and Medical degree at Tufts University in 1986. He completed residency training in internal medicine at New York Hospital-Cornell Medical Center and completed post-doctoral training at NIAID with Dr William Paul studying how cytokines influence CD4+ T helper cell differentiation.

25

Laurence Slutsker, MPH, MDProgram Leader, Malaria and Neglected Tropical Diseases

Director, Center for Malaria Control and EliminationPATH

Dr Laurence (Larry) Slutsker, is the leader of PATH’s Malaria and Neglected Tropical Diseases (NTDs) programs and the director of PATH’s Center for Malaria Control and Elimination. At PATH, he directs activities to advance efforts toward elimination, and ultimately eradication, of both Plasmodium falciparum and Plasmodium vivax malaria. He also oversees PATH’s work as part of a coordinated global effort to stamp out 17 NTDs, directing efforts such as a new rapid diagnostic for onchocerciasis (river blindness) and a new treatment for soil-transmitted helminths, parasitic worms that thrive in places with limited sanitation and hygiene infrastructure.

Before joining PATH in 2016, Dr Slutsker spent 29 years at the U.S. Centers for Disease Control and Prevention (CDC) in a number of leadership roles, including associate director for Science, chief of the Malaria Branch, and director of the CDC/KEMRI Field Station in Kisumu, Kenya. Dr Slutsker most recently served as director of the Division of Parasitic Diseases and Malaria at the CDC Center for Global Health, where he provided strategic leadership for malaria and neglected tropical diseases. He has also been asked to participate in numerous high-level policy and strategy committees and groups, including the Roll Back Malaria Partnership; World Health Organization (WHO) Global Malaria Programme (GMP) as co-chair of the Evidence Review Group Malaria in Pregnancy/IPTp; Malaria Chemotherapy Technical Expert Group; Surveillance, Monitoring and Evaluation Technical Expert Group; and the highest-level malaria advisory group to WHO/GMP, the Malaria Policy Advisory Committee. Dr Slutsker earned a bachelor’s degree at the University of Michigan and master’s degree in Public Health at the University of California, Berkeley. He received a Medical degree from Case Western Reserve University and completed a residency in internal medicine at the University of North Carolina, Chapel Hill.

26

Rick Steketee, MDDeputy U.S. Global Malaria CoordinatorPresident’s Malaria Initiative

Dr Rick Steketee was named in July 2018 as the Deputy U.S. Global Malaria Coordinator for the President’s Malaria Initiative. Dr Steketee is an internationally recognized expert in malaria and a medical epidemiologist with over 30 years of public health experience in infectious diseases. He spent 21 years as an active duty member of the U.S. Public Health Service, with 15 of those years working on malaria at the U.S. Centers for Disease Control and Prevention (CDC). During that time, he spent approximately 5 years in Malawi, evaluating programmatic approaches to controlling malaria in pregnancy and childhood, eventually becoming CDC’s Malaria Branch Chief in 2000.

Subsequently, Dr Steketee joined PATH in 2005 and worked as the Science Director for the Malaria Control Program at PATH supporting field work in sub-Saharan African countries. He was the Director of PATH’s Malaria Control and Elimination Program (MCEP) and Director of the Malaria Control and Elimination Partnership in Africa (MACEPA) since 2015. As the Director of MCEP, he provided leadership across a broad portfolio of malaria programs.

He has worked closely with the World Health Organization (WHO), UNICEF, the World Bank, the Global Fund to Fight HIV, TB and Malaria, and the RBM Partnership to End Malaria and participated on RBM working groups including the Monitoring and Evaluation Working Group, the Harmonization Working Group, the Malaria in Pregnancy Working Group and the Case Management Working Group. Dr Steketee has participated in numerous WHO Expert Review Groups on malaria and is a current member of the WHO Malaria Policy Advisory Committee.

Speaker Biographies

27

Rafael VilasanjuanDirector of Policy and Global Development

Barcelona Institute for Global Health

Mr Rafael Vilasanjuan is a journalist with a degree in Information Sciences from the Autonomous University of Barcelona. Since March 2011, he has served as the Director of Policy and Global Development at the Barcelona Institute for Global Health (ISGlobal). He was Deputy Director of the Centre for Contemporary Culture of Barcelona (CCCB) from 2006 to 2011. He also worked for over 12 years with Médecins Sans Frontieres (MSF), starting as Communication Director in 1995 and later as General Director of the Spanish section of MSF. In 1999, when the organization was awarded the Nobel Prize for peace, he was appointed General Secretary of MSF International until 2005. During this period, he worked in conflict areas such as Afghanistan, Chechnya, Somalia, Sudan, West Africa, the Democratic Republic of Congo and Colombia. He is currently member of the GAVI Civil Society Organizations Steering Committee and President of Exit Foundation. He is also member of the Advisory Board of Democracia Abierta (Open Democracy), among others.

Elizabeth A. Winzeler, PhDProfessor of Pediatrics, School of Medicine

University of California, San Diego

Elizabeth Winzeler is a Professor of Pediatrics in the School of Medicine at the University of California, San Diego. She leads a group that uses systematic, data intensive methods to solve problems at the interface of host pathogen biology typically involving large collections of chemical screening data and whole genome sequencing at the University of California, San Diego. She is a fellow of the American Academy in Microbiology.

Professor Winzeler has published more than 150 publications and she has received awards from the Keck Foundation, the Ellison Medical Foundation, and the Bill & Melinda Gates Foundation. In 2014, she was awarded the Bailey-Ashford Medal by the American Society of Tropical Medicine and Hygiene (ASTMH) for distinguished achievements in tropical medicine; she received the 2017 Medicines of Malaria Venture Project of the Year; and in 2018, she has received the Alice and C.C. Wang Award in Molecular Parasitology and the William Trager Award by the American Committee of Molecular, Cellular and Immunoparasitology and ASTMH.

28

Speaker Biographies

Dyann F. Wirth, PhDPRichard Pearson Strong Professor of Infectious DiseasesHarvard T.H. Chan School of Public HealthSenior Associate MemberBroad Institute

Professor Dyann F. Wirth has been a major leader in malaria research for more than 30 years. Recognizing the importance of bringing cutting-edge genomic science to the study of infectious diseases, she joined the Broad Institute of MIT and Harvard shortly after its establishment to lead its infectious diseases initiative. Today, the Wirth laboratory blends the scientific environments of the Harvard T.H. Chan School of Public Health, the Broad Institute, and research institutions from across the globe to create a unique malaria research and training network that brings together scientists with expertise in molecular biology, genetics, genomics, population genetics, chemistry, cell biology, epidemiology, computational biology, biostatistics, and leading clinicians in infectious diseases and pathology. Using a multidisciplinary approach, her group explores challenges related to mosquito biology and the malaria parasite. Professor Wirth also directs Harvard’s Defeating Malaria: From the Genes to the Globe Initiative, a university-wide effort to produce, transmit, and translate knowledge to support the control and eradication of malaria.

Professor Wirth was the chair of the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health from 2006 to 2018. She is a member and chair of the World Health Organization’s Malaria Policy Advisory Committee, fellow and past president of the American Society of Tropical Medicine & Hygiene (ASTMH), fellow of the American Academy of Microbiology, and member of the National Academy of Medicine of the National Academy of Sciences. She was a recipient of the ASTMH’s Joseph Augustine LePrince Medal and honored with BioMalPar’s Lifetime Achievement Award, and USF President’s Global Leadership Award in 2018. She is a past board member of the Burroughs Wellcome Fund and the Marine Biological Laboratory.

Notes

Collaborators:

Sponsors:

National Institute of Allergy and Infectious Diseases